<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Trimedyne Inc. | Company News & Executive Profiles - TMED | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/trimedyne+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Trimedyne Inc.]]></description>
	<s:counts start="0" returned="10" found="11" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Trimedyne Reports Its Financial Results for the Quarter Ended December 31, 2008]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200902/ai_n31380063]]></link>
		<description><![CDATA[TRIMEDYNE, INC. (OTCBB: TMED) today reported its financial results for the quarter ended December 31, 2008.  Revenues for the quarter were $1,610,000, an increase of 36% from revenues of $1,186,000 for the prior year's quarter.  The $424,000 increase in revenues was due to increases in sales of lasers...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 Feb 2009 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/boston+scientific+corp..html"><![CDATA[Boston Scientific Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/lumenis+ltd..html"><![CDATA[Lumenis Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">BSX,TMED</category>
	</item>
	<item>
		<title><![CDATA[Trimedyne Announces U.S. Patent Office Allowance of Important Patent on New Laser Angioplasty Device]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Oct_25/ai_n6250917]]></link>
		<description><![CDATA[IRVINE, Calif. -- Trimedyne Inc. (OTCBB:TMED) today announced the U.S. Patent Office has allowed its Patent Application on a new laser angioplasty device. The Patent will issue in a few months.  The Patent covers unique optical fiber devices designed to make smooth channels through plaque deposits in arteries, without...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 25 Oct 2004 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/laser.html"><![CDATA[laser]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">TMED</category>
	</item>
	<item>
		<title><![CDATA[Trimedyne Reports Sharply Lower Losses for the Quarter and Nine Months Ended June 30, 2002]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_August_23/ai_90679320]]></link>
		<description><![CDATA[Business Editors  IRVINE, Calif.--BUSINESS WIRE--Aug. 23, 2002  Trimedyne Inc. (Nasdaq:TMED) today announced revenues of $1,896,000 and $5,408,000 for the quarter and nine month period ended June 30, 2002, respectively, compared with revenues of $1,829,000 and $5,445,000 for the quarter and nine month period ended June 30, 2001, respectively....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 23 Aug 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/disc.html"><![CDATA[disc]]></category>
		<category domain="http://resources.bnet.com/topic/laser.html"><![CDATA[laser]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/surgery.html"><![CDATA[surgery]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">NDAQ,TMED</category>
	</item>
	<item>
		<title><![CDATA[SEC Charges Irvine, Calif.-Based Medical Supplier Controller with Fraud.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_199906/ai_n22410265]]></link>
		<description><![CDATA[Knight Ridder/Tribune Business News    Jun. 24 -- A former controller of Trimedyne Inc. and two family  members were charged Wednesday with securities fraud for allegedly  reaping profits on stock they bought days before the company announced  crucial regulatory approval.    Controller Michelle...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 23 Jun 1999 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/fraud.html"><![CDATA[fraud]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/supplier.html"><![CDATA[supplier]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">TMED</category>
	</item>
	<item>
		<title><![CDATA[Gore Horvath Announces Investment Opinion on Trimedyne Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_April_1/ai_54268466]]></link>
		<description><![CDATA[IRVINE, Calif.--BUSINESS WIRE--April 1, 1999--  Research Report on Trimedyne Issued by Gore Horvath  Trimedyne Inc. (Nasdaq:TMED) Thursday announced the issuance of a Research Report and Speculative Buy Recommendation on Trimedyne by Gore Horvath, an investment banking firm with headquarters in Long Beach, Calif.  The Gore Horvath report...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Apr 1999 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/california.html"><![CDATA[California]]></category>
		<category domain="http://resources.bnet.com/topic/gore.html"><![CDATA[Gore]]></category>
		<category domain="http://resources.bnet.com/topic/laser.html"><![CDATA[laser]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">TMED</category>
	</item>
	<item>
		<title><![CDATA[Patent Office Actions Benefit Trimedyne]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_March_8/ai_54035253]]></link>
		<description><![CDATA[IRVINE, Calif.--BUSINESS WIRE--March 8, 1999--Trimedyne Inc. (Nasdaq/NMS:TMED) Monday announced the U.S. Patent and Trademark Office ("USPTO") has completed the re-examination of Trimedyne's U.S. Patent on the use of a laser, drug injector or any other therapeutic device on the heart which is synchronized with the patient's electrocardiogram ("ECG").  The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 08 Mar 1999 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/laser.html"><![CDATA[laser]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">TMED</category>
	</item>
	<item>
		<title><![CDATA[Trimedyne Reports Important Patent Office Actions]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_March_4/ai_54009655]]></link>
		<description><![CDATA[IRVINE, Calif.--BUSINESS WIRE--March 4, 1999--TRIMEDYNE INC. (Nasdaq/NMS: TMED) Thursday announced the U.S. Patent and Trademark Office ("USPTO") has completed the re-examination of Trimedyne's U.S. Patent on the use of a laser or any other therapeutic device on the heart which is synchronized with the patient's electrocardiogram ("ECG"). The Patent was...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 04 Mar 1999 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/laser.html"><![CDATA[laser]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">TMED</category>
	</item>
	<item>
		<title><![CDATA[NASDAQ: Nasdaq halts trading of Trimedyne Inc. and requests additional information from the company.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_199903/ai_n20260406]]></link>
		<description><![CDATA[M2 PRESSWIRE-1 March 1999-NASDAQ: Nasdaq halts trading of  Trimedyne Inc. and requests additional information from the company  C1994-99 M2 COMMUNICATIONS LTD    RDATE:260299    Washington, D.C. -- The Nasdaq Stock Market announced that trading  was halted in Trimedyne Inc. TMED on February 25,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Mar 1999 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">NDAQ,TMED</category>
	</item>
	<item>
		<title><![CDATA[Nasdaq Halts Trading on Irvine, Calif.-Based Firm amid Name Dispute.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_199902/ai_n22389914]]></link>
		<description><![CDATA[Knight Ridder/Tribune Business News    Feb. 27 -- What's in a name? A whole lot of trouble if someone  hijacks it, as Trimedyne Inc. learned Friday.    The Nasdaq exchange halted trading of the company's shares  Friday in the wake of a clerical mishap...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 26 Feb 1999 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nevada.html"><![CDATA[Nevada]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">NDAQ,TMED</category>
	</item>
	<item>
		<title><![CDATA[Trimedyne Receives $6.5 Million Payment]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1998_Dec_7/ai_53358463]]></link>
		<description><![CDATA[IRVINE, Calif.--BUSINESS WIRE--Dec. 7, 1998--Trimedyne Inc. (Nasdaq/NMS:TMED) Monday announced it received the $6.5 million payment from C.R. Bard Inc. due under the settlement agreement reached in late November.  As a result of this payment, Trimedyne's stockholders' equity has increased to approximately $16,870,000 or $1.55 per share as of this...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 07 Dec 1998 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/business+wire.html"><![CDATA[Business Wire]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/laser.html"><![CDATA[laser]]></category>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[payment]]></category>
		<category domain="http://resources.bnet.com/topic/surgery.html"><![CDATA[surgery]]></category>
		<category domain="http://resources.bnet.com/topic/trimedyne+inc..html"><![CDATA[Trimedyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TMED</category>
		<category domain="tickers">TMED</category>
	</item>
</channel>
</rss>
